Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control
Authors:
- 1 October 2012
- journal article
- Published by Elsevier in Practical Radiation Oncology
- Vol. 2 (4) , 288-295
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trialLung Cancer, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Stage I nonsmall cell lung cancer in patients aged ≥75 yearsCancer, 2009
- Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchusLung Cancer, 2009
- Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planningLung Cancer, 2008
- Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional StudyJournal of Thoracic Oncology, 2007
- Stereotactic single‐dose radiotherapy (radiosurgery) of early stage nonsmall‐cell lung cancer (NSCLC)Cancer, 2007
- Stereotactic Radiosurgery for the Treatment of Lung Neoplasm: Initial ExperienceThe Annals of Thoracic Surgery, 2007
- Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumorsActa Oncologica, 2006
- Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinomaCancer, 1998